These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Biologics as cancer treatment modalities. Smalley RV Wis Med J; 1987 Nov; 86(11):19-21. PubMed ID: 2447705 [No Abstract] [Full Text] [Related]
7. Interview with Jean-Pierre Revillard. What is going to happen tomorrow as far as treatment of autoimmune disorders is concerned? Revillard JP Ann Med Interne (Paris); 1997; 148(1):11-4. PubMed ID: 9137693 [No Abstract] [Full Text] [Related]
8. [Immunotherapy in non-allergic diseases]. EspaƱol T Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379 [TBL] [Abstract][Full Text] [Related]
9. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases. Ikehara S J Autoimmun; 2008 May; 30(3):108-15. PubMed ID: 18249091 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease. Alderuccio F; Chan J; Scott DW; Toh BH Trends Mol Med; 2009 Aug; 15(8):344-51. PubMed ID: 19665432 [TBL] [Abstract][Full Text] [Related]
11. [Risks and side effect reactions during therapy with TNF-alpha blockers. An immunologic analysis]. Berg PA Dtsch Med Wochenschr; 2004 Jul; 129(30):1631-4. PubMed ID: 15257503 [No Abstract] [Full Text] [Related]
12. Immunological approaches to the treatment of malignant disease. Guillou PJ J R Coll Surg Edinb; 1988 Feb; 33(1):2-8. PubMed ID: 2458468 [No Abstract] [Full Text] [Related]
13. [Bone marrow cytology in diseases of autoimmune pathogenesis in childhood and its changes during therapy with anti-human lymphocyte globulin (AHLG)]. Exadaktylos P; Rumler W Allerg Immunol (Leipz); 1984; 30(2):83-90. PubMed ID: 6237560 [TBL] [Abstract][Full Text] [Related]
15. [New trends in immunotherapy of rheumatoid arthritis]. Todesco S; Fiocco U; Cozzi L Clin Ter; 1991 Dec 15-31; 139(5-6):257-63. PubMed ID: 1802515 [No Abstract] [Full Text] [Related]
16. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease. Bach JF C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496 [TBL] [Abstract][Full Text] [Related]
17. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?]. Moum B Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118 [No Abstract] [Full Text] [Related]
18. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding]. MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959 [No Abstract] [Full Text] [Related]
19. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis. Girolomoni G; Abeni D Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771 [No Abstract] [Full Text] [Related]
20. Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here? Khanna D; McMahon M; Furst DE Arthritis Rheum; 2004 Apr; 50(4):1040-50. PubMed ID: 15077286 [No Abstract] [Full Text] [Related] [Next] [New Search]